EUVIMEDEUVIMED entdecken
Crossref

MiR-140-3p Improves Sensitivity to Docetaxel by Suppressing PD-L1/ABCG2/MVP Expression in Lung Adenocarcinoma

Minji Kwon, Dayeon Lim, Jayeon Park, World Gil, Jiwoo Jung, Suyeon Jung, Chaeeon Kim, Minjeong Go, Ye Hwang Cheong, Hee Sun Park, Yong-Bin Eom, Sin-Aye Park

Anticancer Research · 2024

DOI: 10.21873/anticanres.17258 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Anticancer Research, 2024. Verfasst von Minji Kwon und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Sciences, Graduate School, Soonchunhyang University, Asan, Republic of Korea. Hauptthemen laut MEDLINE: Docetaxel, MicroRNAs, Adenocarcinoma of Lung, Lung Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DocetaxelMicroRNAsAdenocarcinoma of LungLung NeoplasmsATP Binding Cassette Transporter, Subfamily G, Member 2B7-H1 AntigenDrug Resistance, NeoplasmNeoplasm ProteinsGene Expression Regulation, NeoplasticHumansCell Line, TumorAnimalsMiceCell ProliferationFemaleAntineoplastic AgentsMaleXenograft Model Antitumor Assays

Stichwörter der Autor:innen

Lung adenocarcinomaMiR-140-3pPD-L1docetaxeldrug resistance

Substanzen

DocetaxelMicroRNAsATP Binding Cassette Transporter, Subfamily G, Member 2Mirn140 microRNA, humanB7-H1 AntigenCD274 protein, humanNeoplasm ProteinsABCG2 protein, humanAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Medical Sciences, Graduate School, Soonchunhyang University, Asan, Republic of Korea.
  • Department of Biomedical Laboratory Science, College of Medical Sciences, Soonchunhyang University, Asan, Republic of Korea.
  • Drug Discovery Research Laboratories, Dong-A ST Co., Ltd., Yongin, Republic of Korea.
  • Division of Pulmonology, Department of Internal Medicine, College of Medicine, Chungnam National University, Daejeon, Republic of Korea.
  • Department of Medical Sciences, Graduate School, Soonchunhyang University, Asan, Republic of Korea; sappark@sch.ac.kr.

Zitieren

APA

Kwon, M., Lim, D., Park, J., Gil, W., Jung, J., Jung, S., Kim, C., Go, M., Cheong, Y. H., Park, H. S., Eom, Y. B., & Park, S. A. (2024). MiR-140-3p Improves Sensitivity to Docetaxel by Suppressing PD-L1/ABCG2/MVP Expression in Lung Adenocarcinoma. Anticancer Research. https://doi.org/10.21873/anticanres.17258

Vancouver

Kwon M, Lim D, Park J, Gil W, Jung J, Jung S, et al. MiR-140-3p Improves Sensitivity to Docetaxel by Suppressing PD-L1/ABCG2/MVP Expression in Lung Adenocarcinoma. Anticancer Research. 2024. doi:10.21873/anticanres.17258

BibTeX
@article{Kwon2024,
  author = {Kwon, Minji and Lim, Dayeon and Park, Jayeon and Gil, World and Jung, Jiwoo and Jung, Suyeon and Kim, Chaeeon and Go, Minjeong and Cheong, Ye Hwang and Park, Hee Sun and Eom, Yong-Bin and Park, Sin-Aye},
  title = {MiR-140-3p Improves Sensitivity to Docetaxel by Suppressing PD-L1/ABCG2/MVP Expression in Lung Adenocarcinoma},
  journal = {Anticancer Research},
  year = {2024},
  doi = {10.21873/anticanres.17258}
}
Kostenlos starten →